Genedrive Plc
1 known investors
Genedrive Diagnostics develops and commercialises a rapid point-of-care pharmacogenetic testing platform that detects genetic variants to guide personalised medicine decisions in emergency healthcare. The UK-based company's tests help clinicians tailor drug choices based on a patient's genetics.
Investors · 1
Companies House · registry record
View on Companies House ↗- Registered name
- GENEDRIVE PLC
- Company number
- 06108621
- Status
- Active
- Company type
- Public limited company
- Incorporated
- 15 Feb 2007
- Registered office
- The Incubator Building, Grafton Street, Manchester, M13 9XX
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology
- Previous names
- EPISTEM HOLDINGS PLC (2007–2016)
- Accounts
- last made up to 30 Jun 2025 · next due 31 Dec 2026
- Confirmation statement
- last made up to 21 Jan 2026 · next due 4 Feb 2027
Current officers · 6
- Russell John Shaw — secretary, appointed 7 Apr 2022
- Ian David Gilham — director, appointed 24 Nov 2014
- Gino Miele — director, appointed 11 Sept 2023
- David Grant Nugent — director, appointed 26 May 2026
- Russell John Shaw — director, appointed 7 Apr 2022
- Chris Henry Francis Yates — director, appointed 22 Aug 2018
Source: Companies House public register · retrieved 30 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.
Frequently asked questions
- What does Genedrive Plc do?
- Genedrive Diagnostics develops and commercialises a rapid point-of-care pharmacogenetic testing platform that detects genetic variants to guide personalised medicine decisions in emergency healthcare. The UK-based company's tests help clinicians tailor drug choices based on a patient's genetics.
- Who are Genedrive Plc's investors?
- Genedrive Plc's investors include Seneca Partners.